Drug Shortage Report for AMIODARONE HYDROCHLORIDE FOR INJECTION
| Report ID | 116246 |
| Drug Identification Number | 02242325 |
| Brand name | AMIODARONE HYDROCHLORIDE FOR INJECTION |
| Common or Proper name | AMIODARONE HYDROCHLORIDE FOR INJECTION |
| Company Name | SANDOZ CANADA INCORPORATED |
| Market Status | MARKETED |
| Active Ingredient(s) | AMIODARONE HYDROCHLORIDE |
| Strength(s) | 50MG |
| Dosage form(s) | LIQUID |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 18 ML |
| ATC code | C01BD |
| ATC description | ANTIARRHYTHMICS, CLASS I AND III |
| Reason for shortage | Requirements related to complying with good manufacturing practices. |
| Anticipated start date | |
| Actual start date | 2020-05-29 |
| Estimated end date | 2020-06-05 |
| Actual end date | 2020-06-05 |
| Shortage status | Resolved |
| Updated date | 2020-06-22 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
| Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2020-06-22 | French | Compare |
| v3 | 2020-06-22 | English | Compare |
| v2 | 2020-06-01 | French | Compare |
| v1 | 2020-06-01 | English | Compare |
Showing 1 to 4 of 4